Literature DB >> 11556940

What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia?

E A Halm1, G E Switzer, B S Mittman, M B Walsh, C C Chang, M J Fine.   

Abstract

OBJECTIVE: One of the major factors influencing length of stay for patients with community-acquired pneumonia is the timing of conversion from intravenous to oral antibiotics. We measured physician attitudes and beliefs about the antibiotic switch decision and assessed physician characteristics associated with practice beliefs.
DESIGN: Written survey assessing attitudes about the antibiotic conversion decision.
SETTING: Seven teaching and non-teaching hospitals in Pittsburgh, Pa. PARTICIPANTS: Three hundred forty-five generalist and specialist attending physicians who manage pneumonia in 7 hospitals. MEASUREMENTS AND
RESULTS: Factors rated as "very important" to the antibiotic conversion decision were: absence of suppurative infection (93%), ability to maintain oral intake (79%), respiratory rate at baseline (64%), no positive blood cultures (63%), normal temperature (62%), oxygenation at baseline (55%), and mental status at baseline (50%). The median thresholds at which physicians believed a typical patient could be converted to oral therapy were: temperature < or =100 degrees F (37.8 degrees C), respiratory rate < or =20 breaths/minute, heart rate < or =100 beats/minute, systolic blood pressure > or =100 mm Hg, and room air oxygen saturation > or =90%. Fifty-eight percent of physicians felt that "patients should be afebrile for 24 hours before conversion to oral antibiotics," and 19% said, "patients should receive a standard duration of intravenous antibiotics." In univariate analyses, pulmonary and infectious diseases physicians were the most predisposed towards early conversion to oral antibiotics, and other medical specialists were the least predisposed, with generalists being intermediate (P <.019). In multivariate analyses, practice beliefs were associated with age, inpatient care activities, attitudes about guidelines, and agreeableness on a personality inventory scale.
CONCLUSIONS: Physicians believed that patients could be switched to oral antibiotics once vital signs and mental status had stabilized and oral intake was possible. However, there was considerable variation in several antibiotic practice beliefs. Guidelines and pathways to streamline antibiotic therapy should include educational strategies to address some of these differences in attitudes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11556940      PMCID: PMC1495262          DOI: 10.1046/j.1525-1497.2001.016009599.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  22 in total

1.  The radiographic resolution of Streptococcus pneumoniae pneumonia.

Authors:  S J Jay; W G Johanson; A K Pierce
Journal:  N Engl J Med       Date:  1975-10-16       Impact factor: 91.245

2.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

3.  Differences in length of hospital stay in patients with community-acquired pneumonia: a prospective four-hospital study.

Authors:  M J Fine; D E Singer; A L Phelps; B H Hanusa; W N Kapoor
Journal:  Med Care       Date:  1993-04       Impact factor: 2.983

4.  Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association.

Authors:  M S Niederman; J B Bass; G D Campbell; A M Fein; R F Grossman; L A Mandell; T J Marrie; G A Sarosi; A Torres; V L Yu
Journal:  Am Rev Respir Dis       Date:  1993-11

Review 5.  Community-acquired pneumonia.

Authors:  T J Marrie
Journal:  Clin Infect Dis       Date:  1994-04       Impact factor: 9.079

6.  Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia.

Authors:  J A Ramirez; S Vargas; G W Ritter; M E Brier; A Wright; S Smith; D Newman; J Burke; M Mushtaq; A Huang
Journal:  Arch Intern Med       Date:  1999-11-08

7.  Variations in length of stay and outcomes for six medical and surgical conditions in Massachusetts and California.

Authors:  P D Cleary; S Greenfield; A G Mulley; S G Pauker; S A Schroeder; L Wexler; B J McNeil
Journal:  JAMA       Date:  1991-07-03       Impact factor: 56.272

8.  Internists' attitudes about clinical practice guidelines.

Authors:  S R Tunis; R S Hayward; M C Wilson; H R Rubin; E B Bass; M Johnston; E P Steinberg
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

9.  Comparative radiographic features of community acquired Legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia, and psittacosis.

Authors:  J T Macfarlane; A C Miller; W H Roderick Smith; A H Morris; D H Rose
Journal:  Thorax       Date:  1984-01       Impact factor: 9.139

10.  The effects of patient, hospital, and physician characteristics on length of stay and mortality.

Authors:  L R Burns; D R Wholey
Journal:  Med Care       Date:  1991-03       Impact factor: 2.983

View more
  17 in total

1.  Managing community-acquired pneumonia.

Authors:  J G Bartlett
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

2.  Cost of infectious diseases.

Authors:  C Ruef
Journal:  Infection       Date:  2002-04       Impact factor: 3.553

3.  Categorical Risk Perception Drives Variability in Antibiotic Prescribing in the Emergency Department: A Mixed Methods Observational Study.

Authors:  Eili Y Klein; Elena M Martinez; Larissa May; Mustapha Saheed; Valerie Reyna; David A Broniatowski
Journal:  J Gen Intern Med       Date:  2017-06-20       Impact factor: 5.128

4.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

5.  Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis.

Authors:  Zoe Athanassa; Gregory Makris; George Dimopoulos; Matthew E Falagas
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Modern Management of Community-Acquired Pneumonia: Is It Cost-Effective and are Outcomes Acceptable?

Authors:  Dominik Mertz; Jennie Johnstone
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

7.  Patients' and Clinicians' Perceptions of Antibiotic Prescribing for Upper Respiratory Infections in the Acute Care Setting.

Authors:  David A Broniatowski; Eili Y Klein; Larissa May; Elena M Martinez; Chelsea Ware; Valerie F Reyna
Journal:  Med Decis Making       Date:  2018-07       Impact factor: 2.583

8.  Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study.

Authors:  Jeroen A Schouten; Marlies E J L Hulscher; Stephanie Natsch; Bart-Jan Kullberg; Jos W M van der Meer; Richard P T M Grol
Journal:  Qual Saf Health Care       Date:  2007-04

Review 9.  Improving outcomes of elderly patients with community-acquired pneumonia.

Authors:  Félix Gutiérrez; Mar Masiá
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Outcomes of early switching from intravenous to oral antibiotics on medical wards.

Authors:  Dominik Mertz; Michael Koller; Patricia Haller; Markus L Lampert; Herbert Plagge; Balthasar Hug; Gian Koch; Manuel Battegay; Ursula Flückiger; Stefano Bassetti
Journal:  J Antimicrob Chemother       Date:  2009-04-28       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.